Oral anticoagulation with Factor Xa and thrombin inhibitors: Is there an alternative to warfarin?
Authors : Zikria Jennifer J; Ansell Jack J;
Affiliations : New York Presbyterian Hospital, New York, New York 10032, USA.
Journal : Discov Med (2009)
Related Links: Pubmed | Publisher website N/A
Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale.
Authors : Lopes Renato D RD; Alexander John H JH; Al-Khatib Sana M SM; Ansell Jack J; Diaz Raphael R; Easton J Donald JD; Gersh Bernard J BJ; Granger Christopher B CB; Hanna Michael M; Horowitz John J; Hylek Elaine M EM; McMurray John J V JJ; Verheugt Freek W A FW; Wallentin Lars L; ;
Affiliations : Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA.
Journal : Am. Heart J. (2010)
Related Links: Pubmed | Publisher website
Outcomes registry for better informed treatment of atrial fibrillation: Rationale and design of ORBIT-AF.
Authors : Piccini JP; Fraulo ES; Ansell JE; Fonarow GC; Gersh BJ; Go AS; Hylek EM; Kowey PR; Mahaffey KW; Thomas LE; Kong MH; Lopes RD; Mills RM;
Affiliations : Duke Clinical Research Institute, Durham, NC.
Journal : American Heart Journal (2011)
Related Links: Pubmed | Publisher website
Outcomes registry for better informed treatment of atrial fibrillation: Rationale and design of ORBIT-AF
Authors : Piccini JP; Fraulo ES; Ansell JE; Fonarow GC; Gersh BJ; Go AS; Hylek EM; Kowey PR; Mahaffey KW; Thomas LE; Kong MH; Lopes RD; Mills RM;
Affiliations : Duke Clinical Research Institute, Durham, NC Reprint requests: Jonathan P. Piccini, MD, MHS, PO Box 17969, Durham, NC 27710
Journal : American Heart Journal (2011)
Related Links: Pubmed | Publisher website
Display Ads on JAFIB to reach Users world wide...
Suggest an Event to get good mileage from Users World wide...